Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Blood

• Publication date

  2012-11-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood-2012-07-445304PMID 23047823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis.

  2012cited by this paper
• Membranoproliferative glomerulonephritis--a new look at an old entity.

  2012cited by this paper
• Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis.

  2012cited by this paper
• Lenalidomide after stem-cell transplantation for multiple myeloma.

  2012influential reference
• Treatment of multiple myeloma

  2011cited by this paper
• Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival.

  2011cited by this paper
• Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft.

  2011cited by this paper
• Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation.

  2011cited by this paper
• Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience.

  2011cited by this paper
• stem cell transplantation: long-term results in a series of 421 patients Outcome of AL amyloidosis after high-dose melphalan and autologous

  2011cited by this paper
• Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.

  2010cited by this paper
• Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group.

  2010cited by this paper
• Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report

  2010cited by this paper
• Recurrent membranoproliferative glomerulonephritis after kidney transplantation.

  2010cited by this paper
• Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

  2010influential reference
• A case of bilateral renal arterial thrombosis associated with cryocrystalglobulinaemia

  2009cited by this paper
• Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens.

  2009cited by this paper
• Treatment of light chain deposition disease with bortezomib and dexamethasone

  2009cited by this paper
• Proliferative glomerulonephritis with monoclonal IgG deposits.

  2009cited by this paper
• Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.

  2009cited by this paper
• Screening panels for detection of monoclonal gammopathies.

  2009cited by this paper
• Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits.

  2009cited by this paper
• High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease

  2008cited by this paper
• Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma.

  2008cited by this paper
• Long-term outcome of autologous stem cell transplantation in light chain deposition disease.

  2008cited by this paper
• High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.

  2008cited by this paper
• Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.

  2008cited by this paper
• Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma.

  2007cited by this paper
• Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.

  2007cited by this paper
• Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis.

  2007cited by this paper
• High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.

  2007cited by this paper
• Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation

  2006cited by this paper
• Dangerous small B-cell clones.

  2006cited by this paper
• A proliferative glomerulonephritis secondary to a monoclonal IgA.

  2006cited by this paper
• Prevalence of monoclonal gammopathy of undetermined significance.

  2006cited by this paper
• Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.

  2005cited by this paper
• Fibrillary glomerulonephritis associated with monoclonal gammopathy of undetermined significance showing lambda-type Bence Jones protein

  2005cited by this paper
• Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.

  2005cited by this paper
• High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study

  2004cited by this paper
• Long-term outcome of renal transplantation in light-chain deposition disease.

  2004cited by this paper
• Dysproteinemia and the Kidney

  2004cited by this paper
• Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.

  2003cited by this paper
• Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.

  2003cited by this paper
• Monoclonal gammopathy: significance and possible causality in renal disease.

  2003cited by this paper
• Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.

  2003cited by this paper
• Single versus double autologous stem-cell transplantation for multiple myeloma.

  2003cited by this paper
• Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features.

  2002cited by this paper
• Recurrence of Light Chain Nephropathy in a Renal Allograft

  2001cited by this paper
• Renal monoclonal immunoglobulin deposition disease: the disease spectrum.

  2001cited by this paper
• Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution.

  1998cited by this paper
• Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only.

  1996cited by this paper
• Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

  1995influential reference
• Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy.

  1993cited by this paper
• Long-term follow-up and response to chemotherapy in patients with light-chain deposition disease.

  1992cited by this paper
• Nephrotoxic potential of Bence Jones proteins.

  1991cited by this paper
• VAD‐based regimens as primary treatment for multiple myeloma

  1990cited by this paper
• A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults.

  1987cited by this paper
• Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine.

  1985cited by this paper
• Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo.

  1978cited by this paper
• Waldenström's macroglobulinemia, mesangio-capillary glomerulonephritis, angiitis and myositis.

  1973cited by this paper
• THE TREATMENT OF MULTIPLE MYELOMA

  1948cited by this paper

• Serial Ultrastructural/Proteomic Observations in Light- and Heavy-Chain Deposition Disease

  2026cites this paper
• Next-generation Bruton’s tyrosine kinase inhibitors for chronic lymphocytic leukemia-associated membranoproliferative glomerulonephritis: a case report

  2026cites this paper
• Inconsistency between serum IgG κ and glomerular IgA λ chain types in proliferative glomerulonephritis with monoclonal deposits successfully treated with daratumumab-based therapy

  2026cites this paper
• Monoclonal gammopathy of renal significance in western China: A large cohort study dominated by amyloidosis with distinct clinical outcomes.

  2026cites this paper
• Autoinflammatory Gammopathies: When Clinical Significance is Inflammation

  2026cites this paper
• Clinical predictors of monoclonal gammopathy of renal significance: a multicenter study in Japan

  2025cites this paper
• Quantitative abnormalities in the β-region of the electrophoretic profile of serum proteins as predictive markers of monoclonality: Machine learning for monoclonality prediction.

  2025cites this paper
• 5th International Renal Pathology Conference in Zagreb, Croatia: Meeting Report

  2025cites this paper
• Monoclonal gammopathy of renal significance: overlap of AL amyloidosis and immunotactoid glomerulopathy

  2025cites this paper
• The Clinical and Pathological Characteristics of Patients with Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits

  2025cites this paper
• Concurrent presentation of proliferative glomerulonephritis with monoclonal immunoglobulin deposits and light chain proximal tubulopathy: a case report and review of the literature

  2025cites this paper
• Ten tips for an onco-nephrology clinic

  2025cites this paper
• Monoclonal Immunotactoid Glomerulopathy Associated With Chronic Lymphocytic Leukemia: A Case Report

  2025cites this paper
• Kidney damage in chronic lymphocytic leukemia

  2025cites this paper
• Repeated Kidney Biopsy in Membranoproliferative Glomerulonephritis

  2025cites this paper
• Monoclonal Gammopathy of Undetermined Significance.

  2025cites this paper
• Multiple Myeloma With Renal Pathological Findings of Both Light Chain-Only Variant of Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits (PGNMID-LC) and Light Chain Deposition Disease (LCDD)

  2025cites this paper
• A rare concurrence of monoclonal gammopathies in an older adult with tubulointerstitial nephritis and uveitis syndrome

  2025cites this paper
• Monoclonal gammopathy of renal significance presenting as cryoglobulinaemic vasculitis in a frail elderly patient

  2025cites this paper
• Clonal Hematopoiesis of Indeterminate Potential: A Review of its Cardiorenal Implications and Aging.

  2025cites this paper
• Monoclonal gammopathy from nephrology perspective

  2025cites this paper
• Monoclonal gammopathy of renal significance: From bench to bedside

  2025cites this paper
• Treatment of monoclonal gammopathy of renal significance with manifestations of Light Chain Deposition Disease (LCDD) in the transplanted kidney

  2025cites this paper
• Autologous stem cell transplantation for the treatment of MGRS (monoclonal gammopathy of renal significance): experience from the University of Calgary.

  2025cites this paper
• Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID): three Case Reports and systematic review

  2025cites this paper
• Clonal disorders of clinical significance. A concept with important therapeutic implications

  2025cites this paper
• Where are the immunoglobulins? A review of non-secretory multiple myeloma

  2025cites this paper
• Monoclonal gammopathy of renal significance from a hematologic perspective.

  2025cites this paper
• Heavy Chain Deposition Disease in Monoclonal Gammopathy of Renal Significance: A Prodrome of Multiple Myeloma Case and Literature Review

  2025cites this paper
• Insights into proliferative glomerulonephritis with monoclonal immunoglobulin deposits – is it really monoclonal or not?

  2025cites this paper
• Renal Pathology Society/International Kidney and Monoclonal Gammopathy Research Group Consensus on Pathologic Definitions and Terminology of Monoclonal Gammopathy Associated Kidney Lesions.

  2025cites this paper
• Spectrum of renal diseases caused by monoclonal immunoglobulin: experience from an Australian tertiary referral centre over a 10-year period.

  2025cites this paper
• Can we identify individuals at risk to develop multiple myeloma? A machine learning‐based predictive model

  2025cites this paper
• Bibliometric and Bioinformatics Analysis of Renal Impairment in Multiple Myeloma: Trends and Research Hotspots, and Associated Genetic Pathways (2000-2023)

  2025cites this paper
• A case of renal damage induced by cryoglobulinemia associated with Monoclonal Gammopathy of Renal Significance

  2025cites this paper
• Mixed Cryoglobulinemia in the Setting of Monoclonal B-Cell Lymphocytosis and Monoclonal Gammopathy of Unknown Significance: A Case Report

  2025cites this paper
• Progression of IgM Monoclonal Gammopathy of Renal Significance (MGRS) to Symptomatic Waldenström Macroglobulinemia: A Case Report

  2025cites this paper
• Monoclonal Gammopathy associates with Kidney Failure in ANCA-Associated Vasculitis.

  2025cites this paper
• Monoclonal immunoglobulin deposition disease a spectrum? The treatment of an unusual biopsy presentation

  2024cites this paper
• Monoclonal gammopathy‐associated peripheral neuropathies: Uncovering pearls and challenges

  2024cites this paper
• SOHO State of the Art Updates and Next Questions: Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma.

  2024cites this paper
• Transplantation rénale au cours des maladies rénales associées aux gammapathies monoclonales

  2024cites this paper
• Behandlung von nephrologischen und ossären Komplikationen beim multiplen Myelom

  2024cites this paper
• Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population‐based screening study

  2024cites this paper
• Daratumumab for Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Kidney Allograft: A Case Report

  2024cites this paper
• Suspect the unexpected: proliferative glomerulonephritis with monoclonal immunoglobulin deposits and a negative hematological work-up. A case of monoclonal gammopathy of renal significance

  2024cites this paper
• Effect of monoclonal gammopathy in the progression of acute kidney injury and chronic kidney disease: a retrospective observational study

  2024cites this paper
• Clinical Presentation and Long‐Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective Study

  2024cites this paper
• Unusual Cases of Monoclonal Gammopathy of Renal Significance

  2024cites this paper
• Monoclonal Gammopathy of Clinical Significance (MGCS) and Related Disorders: A Review and the Role of Imaging

  2024cites this paper
• The Monoclonal Gammopathies of Renal Significance

  2024cites this paper
• Renal manifestations of MGUS.

  2024cites this paper
• Adopting the new iStopMM-based criteria for light-chain monoclonal gammopathy of undetermined significance: an ongoing debate

  2024cites this paper
• Updates on C3 Glomerulopathy in Kidney Transplantation: Pathogenesis and Treatment Options

  2024cites this paper
• Development and validation of a diagnostic nomogram model for predicting monoclonal gammopathy of renal significance

  2024cites this paper
• Plasma Cell Tumors in Hematological Classifications of 2022: WHO-HAEM5 (WHO, 5th edition) and ICC (International Consensus Classification). A Clinician’s View

  2024cites this paper
• Proliferative glomerulonephritis with monoclonal immunoglobulin deposits in the native or posttransplant kidney.

  2024cites this paper
• Monoclonal Gammopathies and CKD Progression: An Unfinished Story.

  2024cites this paper
• Long‐term renal survival of γ3‐heavy‐chain deposition disease complicated by heart failure: A case report

  2024cites this paper
• Gammapathies monoclonales de signification rénale

  2024cites this paper
• Clinical Spectrum of Monoclonal Protein and the Factors Associated with Lymphoplasmacytic Malignancies

  2024cites this paper
• Clinical characteristics of monoclonal immunoglobulin-associated renal disease: a retrospective cohort study

  2024cites this paper
• Diagnostic and Therapeutic Aspects of Monoclonal Gammopathies of Renal Significance (MGRS): An Update

  2024cites this paper
• Paraprotein-Mediated Glomerular Diseases.

  2024cites this paper
• Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: Update on laboratory tests for the study of monoclonal gammopathies

  2023cites this paper
• Label-free MXene-assisted field effect transistor for the determination of IL-6 in patients with kidney transplantation infection

  2023cites this paper
• Blood is always thicker than water – A case of renal involvement in waldenstrom's macroglobulinemia

  2023cites this paper
• Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study

  2023cites this paper
• Monoklonale Gammopathie unklarer Signifikanz und Smoldering Multiples Myelom

  2023cites this paper
• Assessment of current clinical practice throughout the UK for the diagnosis and management of monoclonal gammopathy of renal significance

  2023cites this paper
• Investigation and management of the monoclonal gammopathy of undetermined significance

  2023cites this paper
• Monoclonal gammopathies of renal significance

  2023cites this paper
• Relapse of Monoclonal Gammopathy of Renal Significance after mRNA COVID-19 Vaccination: A Case Report

  2023cites this paper
• Spectrum of renal involvement in MGRS patients: a 6-year study

  2023cites this paper
• Diagnostic and Prognostic Comparison of Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3 Glomerulopathy

  2023cites this paper
• Multimorbidity in patients with monoclonal gammopathy of undetermined significance

  2023cites this paper
• [Latest updates on immunotactoid glomerulopathy and fibrillary glomerulonephritis].

  2023cites this paper
• Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study

  2023cites this paper
• Daratumumab in the treatment of C3 glomerulopathy with monoclonal gammopathy: a case report and literature review

  2023cites this paper
• Proliferative glomerulonephritis with monoclonal immunoglobulin G3 lambda deposits accompanied by glomerular positive staining for nephritis-associated plasmin receptor and related plasmin activity: A report of two cases

  2023cites this paper
• Usefulness of the Free Light Chains Ratio in the Diagnosis of Light Chain Deposition Disease (LCDD): A Case Report.

  2023cites this paper
• Post-Transplant Monoclonal Gammopathy of Renal Significance: A Case Report.

  2023cites this paper
• Nonviral cryoglobulinemic vasculitis: an updated review for clinical practice

  2023cites this paper
• Monoclonal Gammopathy and Its Association with Progression to Kidney Failure and Mortality in Patients with CKD

  2023cites this paper
• Waldenström’s Macroglobulinemia and Cryoglobulinemic Glomerulonephritis: An Unusual Case of Monoclonal Gammopathy of Renal Significance

  2023cites this paper
• Clinical Outcomes of Monoclonal Gammopathy of Renal Significance Without Detectable Clones

  2023cites this paper
• Association of monoclonal gammopathy of undetermined significance and C3 glomerulopathy

  2023cites this paper
• Management of Renal Failure in Multiple Myeloma

  2023cites this paper
• Cryocrystalglobulinemia Leading to Multi-Organ Failure in Chronic Lymphocytic Leukemia Achieving Complete Renal Recovery

  2023cites this paper
• The Role of Bone Marrow Biopsy Evaluation in the Workup for Monoclonal Gammopathy of Renal Significance: A Diagnosis of Exclusion.

  2023cites this paper
• Monoclonal Gammopathy of Renal Significance and Thrombotic Microangiopathy: A Case Report

  2022influential citation
• Kidney transplantation in patients with monoclonal gammopathy of renal significance

  2022cites this paper
• Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology

  2022cites this paper
• Paraproteinämien und Nierenbeteiligung

  2022cites this paper
• Plasma cell neoplasms and related entities—evolution in diagnosis and classification

  2022cites this paper
• Monoclonal Gammopathy of Undetermined Significance

  2022cites this paper
• Monoclonal gammopathy of undetermined signifikace (MGUS and monoclonal gammopathy of clinical significance (MGCS)

  2022cites this paper
• Use of daratumumab in a patient with proliferative glomerulonephritis with monoclonal immunoglobulin deposition: A case report

  2022cites this paper
• Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study

  2022cites this paper
• Clinicopathological features and individualized treatment of kidney involvement in B-cell lymphoproliferative disorder

  2022cites this paper